The largest database of trusted experimental protocols

8 protocols using cd11b bv650

1

Simultaneous Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh tumor samples were minced and enzymatically digested with the tumor dissociation kit (Miltenyi #130-096-730) for 40 min at 37°C with agitation. The cell suspension was strained through a 100 μm strainer, spun down and resuspended in 2% FCS/PBS. Cells were blocked for 10 min on ice with anti-mouse CD16/CD32 FC block (Biolegend, 1:100) and stained with Zombie Aqua Fixable Viability Kit (Biolegend, 1:500) and the following antibody cocktails: CD4 BUV805 (BD, 1:100), CD3εBUV395 (BD, 1:20), CD8a BV785 (Biolegend, 1:100), CD45 PerCP Cy5.5 (Biolegend, 1:100), CD19 FITC (Biolegend, 1:100), EpCAM APC/AF647 (Biolegend, 1:200) for acquisition of adaptive immune cells; CD11c BUV737 (BD, 1:30), NK1.1 BUV395 (BD, 1:25), Ly6C BV785 (Biolegend, 1:200), CD11b BV650 (Biolegend, 1:100), F4/80 BV421/PB (Biolegend, 1:30), CD45 PerCP Cy5.5 (Biolegend, 1:100), Ly6G PE (Biolegend, 1:200), CD68 APC-CY7 (Biolegend, 1:20), EpCAM APC/AF647 (Biolegend, 1:200) for acquisition of innate immune cells. Per panel 1,000,000 events were acquired on the BD LSRFortessa. Flow cytometry data was analyzed using FlowJo software (v10.6.2).
+ Open protocol
+ Expand
2

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow-cytometry antibodies included CD3e-PE, PD1-BV605, CD45-BV786 (BD-Biosciences), CD90.1-FITC, CD62L-PECy7, CD45.1-APC, CD45.1-PE (eBioscience), CD45.2-Alexa700, CD-8α-Percp-Cy5.5, CD4-FITC, CD103-APC, CD24-APCcy7 (Invitrogen), CD44-APCy7, CD4-BV421, F4/80-PercpCy5.5, CD39-PECy7, PDL1-PE, CD90.2-Alexa 700, MHCII-BV421, CD11b-BV650, Ly6C-BV711 (Biolegend), CD8α-PE-Texas-red (Life Technologies, Carlsbad, CA, USA). Blocking PD-1 antibody (clone RMP1-14, BioXCell, Branford, CT, USA) was administered systemically by intraperitoneal injections of 250 μg [41 (link)]. Blocking anti-CD40L (clone MR1, BioXCell) was administered systemically by intraperitoneal injections of 250 μg [19 (link)].
+ Open protocol
+ Expand
3

Flow Cytometry Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions of blood (by cardiac puncture) were collected from NRL-CV, NRL and wild-type adult male and female mice and stained for flow cytometry. Antibodies used: CD3-BV785 (17A2, BD Biosciences, cat 564010), CD45-BV711 (30-F11, Biolegend, cat 103147), CD4-PE-Cy7 (RM4–4, Biolegend, cat 116016), CD8-BUV395 (53–6.7, BD Bioscience, cat 563786), CD19-BV605 (6D5, Biolegend, cat 115540), NKp46-BUV737 (29A1.4, BD Bioscience, cat 612805), LY6G-APC-Cy7 (1A8, Biolegend, cat 127623), CD11b-BV650 (M1/70, Biolegend, cat 101259), SiglecF-AF647 (E50–2440, BD Bioscience, cat 562680), CD64-PerCPCy5.5 (X54–5/7.1, Biolegend, cat 139308), TCRγδ-FITC (GL3, Biolegend, cat 118105), CD11c-BV510 (N418, Biolegend, cat 117353) and counterstained with DAPI (ThermoFisher, cat D1306). Samples were acquired on a BD Fortessa instrument. Data were analysed using FlowJo v10.8.1. For cell gating, RFP+ cells were subgated out of CD45+DAPI− single and the immune subsets were subgated out of the RFP+ gate (see Table 1 and Supplementary Figure 4a).
+ Open protocol
+ Expand
4

Multiparametric Flow Cytometry of Tumor Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dissociation of fresh tumor samples and antibody staining was performed as described previously40 (link). Cells were blocked with anti-mouse CD16/CD32 FC block (Biolegend, 1:100) for 10 min on ice and stained with Zombie Aqua Fixable Viability Kit (Biolegend, 1:500) to discriminate live and dead cells. The following antibody cocktails were used: CD4 BUV805 (BD, 1:100), CD3εBUV395 (BD, 1:20), CD8a BV785 (Biolegend, 1:100), CD25 BV650 (Biolegend, 1:50), TCRγ/δ BV421 (Biolegend, 1:100), CD62L PE (Biolegend, 1:500), CD44 APC-Fire (Biolegend, 1:30), CD45 PerCP Cy5.5 (Biolegend, 1:100), CD19 FITC (Biolegend, 1:100), EpCAM APC/AF647 (Biolegend, 1:200) for acquisition of adaptive immune cells; CD11c BUV737 (BD, 1:30), NK1.1 BUV395 (BD, 1:25), Ly6C BV785 (Biolegend, 1:200), CD11b BV650 (Biolegend, 1:100), F4/80 BV421/PB (Biolegend, 1:30), CD45 PerCP Cy5.5 (Biolegend, 1:100), Ly6G PE (Biolegend, 1:200), CD68 APC-CY7 (Biolegend, 1:20), EpCAM APC/AF647 (Biolegend, 1:200) for acquisition of innate immune cells. 1 × 106  events were acquired per antibody panel on the BD LSRFortessa. Flow cytometry data were analyzed using FlowJo software (v10.6.2).
+ Open protocol
+ Expand
5

Isolation and Flow Cytometry of Peritoneal Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peritoneal immune cells were harvested as described previously (98 (link)). Briefly, mice treated with LNPs containing Cy5-mRNA were euthanized before peritoneal cell harvest. Ice-cold PBS (5 ml; Invitrogen, Carlsbad, CA) supplemented with 5% fetal bovine serum (FBS; Invitrogen, Carlsbad, CA) was injected into the peritoneal cavity, which was gently massaged to dislodge attached cells into the solution. PBS was subsequently recollected into the syringe, ensuring minimal blood contamination, and transferred to tubes kept on ice. Cells were collected by centrifugation at 500g and resuspended in PBS and 5% FBS for staining. Cells were stained with the following antibodies in the presence of 1:1000 TruStain FcX antibody (BioLegend): CD19-BV421 (BioLegend, 115537), CD3–fluorescein isothiocyanate (BioLegend, 100203), CD11b-BV650 (BioLegend, 101239), and F4/80-allophycocyanin/Cy7 (BioLegend, 157315), all diluted 1:100. Flow cytometry was performed using a NovoCyte 3000 flow cytometer, and data were analyzed in NovoExpress (Agilent, Santa Clara, CA).
+ Open protocol
+ Expand
6

Comprehensive Murine and Human Immune Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry antibodies for murine samples included CD3e-PE, PD1-BV605, CD45-BV786 (BDbiosciences), CD90.1-FITC, CD62L-PECy7, CD45.1-PE (ebioscience), CD45.2-Alexa700, CD-8α-Percp Cy5.5, CD4-FITC, CD103-APC, CD24-APCcy7 (Invitrogen), CD44-APCy7, CD4-BV421, F4/80-PercpCy5.5, CD39-PECy7, PDL1-PE, CD90.2-Alexa 700, MHCII-BV421, CD11b-BV650, Ly6C-BV711 (Biolegend), CD8α-PE-Texas red (life technologies), CD278 (ICOS)-PE (Biolegend). Flow cytometry antibodies for human samples included CD45-BV510, CD3-Alexa700, CD4-BV785, CD8-BV711, CTLA-4-PE/Dazzle 594, 4-1BB-PE (Biolegend), CD39-BV650, PD-1-PE-Cy7 and Ki-67 Alexa 488 (BD Biosciences), CD103-APC and FOXP3-Alexa 700 (eBioscience).
Mouse antibodies for the explant assays included anti-PD1 (RMP1-14) and anti-CTLA-4 (9D9) by BioXCell and OX40 (OX86) kindly provided by Dr. Andrew Weinberg (EACRI). Human antibodies for the explant assays included anti-PD1 and anti-CTLA4 purchased from Invitrogen and anti-OX40 kindly provided by Dr. Andrew Weinberg (EACRI).
+ Open protocol
+ Expand
7

Simultaneous Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh tumor samples were minced and enzymatically digested with the tumor dissociation kit (Miltenyi #130-096-730) for 40 min at 37°C with agitation. The cell suspension was strained through a 100 μm strainer, spun down and resuspended in 2% FCS/PBS. Cells were blocked for 10 min on ice with anti-mouse CD16/CD32 FC block (Biolegend, 1:100) and stained with Zombie Aqua Fixable Viability Kit (Biolegend, 1:500) and the following antibody cocktails: CD4 BUV805 (BD, 1:100), CD3εBUV395 (BD, 1:20), CD8a BV785 (Biolegend, 1:100), CD45 PerCP Cy5.5 (Biolegend, 1:100), CD19 FITC (Biolegend, 1:100), EpCAM APC/AF647 (Biolegend, 1:200) for acquisition of adaptive immune cells; CD11c BUV737 (BD, 1:30), NK1.1 BUV395 (BD, 1:25), Ly6C BV785 (Biolegend, 1:200), CD11b BV650 (Biolegend, 1:100), F4/80 BV421/PB (Biolegend, 1:30), CD45 PerCP Cy5.5 (Biolegend, 1:100), Ly6G PE (Biolegend, 1:200), CD68 APC-CY7 (Biolegend, 1:20), EpCAM APC/AF647 (Biolegend, 1:200) for acquisition of innate immune cells. Per panel 1,000,000 events were acquired on the BD LSRFortessa. Flow cytometry data was analyzed using FlowJo software (v10.6.2).
+ Open protocol
+ Expand
8

Microglial Isolation and Sorting

Check if the same lab product or an alternative is used in the 5 most similar protocols
As before,
10 (link) 2 h before sacrifice, mice were intraperitoneally injected with methoxy‐X04 5 mg/kg (2 mg/ml dissolved 1 to 1 into dimethyl sulfoxide (DMSO) and resuspended 0.9% saline solution). After intracardial perfusion, microglia was isolated by mechanical dissociation and density gradient. The density gradient was generated resuspending the cell pellet in 70% Percoll in PBS overlayed with 37% Percoll solution in PBS and centrifuged at 2000 g for 20 min in a refrigerated centrifuge. Microglia was obtained by the 37‐70% Percoll gradient and washed 1:5 in ice‐cold PBS and spun at maximum speed in refrigerated microcentrifuge for 1 min. Microglia cells were isolated with FACSAria™ III cell sorter (BD Biosciences) after staining with CD11b‐BV650 (1:200 Biolegend, 141723), CD45‐BV786 (1:200, BD Biosciences 564225), and CX3CR1‐FITC (1:100, Biolegend, 149019). Microglia were gated as live (propidium iodide negative), CD11b+, CD45+, CX3CR1+ single cells, and Me‐X04+ and Me‐X04 microglial populations in transgenic 5xFAD mice were sorted separately for further analysis (Supplementary Figure S2). The flow cytometry results were analyzed using FlowJo™ Software v10.8 Software (Becton, Dickinson and Company; 2023).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!